Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca

In a significant development, President Trump announced a new prescription drug deal with pharmaceutical giant AstraZeneca, crediting his 100-percent tariff threat as a key factor in making the agreement possible. This deal is expected to lower drug prices for Americans, showcasing the administration's commitment to addressing healthcare costs. It highlights the ongoing efforts to negotiate better terms with pharmaceutical companies, which could have a lasting impact on the industry and consumers alike.